56 related articles for article (PubMed ID: 3580508)
21. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
22. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
23. Splenic metastases in a large unselected autopsy series.
Schön CA; Görg C; Ramaswamy A; Barth PJ
Pathol Res Pract; 2006; 202(5):351-6. PubMed ID: 16488085
[TBL] [Abstract][Full Text] [Related]
24. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
[TBL] [Abstract][Full Text] [Related]
25. Serum sialic acid elevations in malignant melanoma patients.
Silver HK; Rangel DM; Morton DL
Cancer; 1978 Apr; 41(4):1497-9. PubMed ID: 639006
[TBL] [Abstract][Full Text] [Related]
26. The evaluation of putative tumor markers for malignant melanoma.
Reintgen DS; Cruse CW; Wells KE; Saba HI; Fabri PJ
Ann Plast Surg; 1992 Jan; 28(1):55-9. PubMed ID: 1642407
[TBL] [Abstract][Full Text] [Related]
27. Sialyltransferase levels and sialic acid concentrations in sera of patients with malignant melanomas.
Herrmann WP; Gielen W
Arch Dermatol Res; 1979 Jul; 265(3):321-9. PubMed ID: 475455
[TBL] [Abstract][Full Text] [Related]
28. Serum sialic acid concentrations in malignant melanoma.
Ryan AH; Fennelly JJ
Eur J Cancer Clin Oncol; 1981 Jul; 17(7):843-4. PubMed ID: 7199476
[No Abstract] [Full Text] [Related]
29. Immunomodulation by bacterial fractions.
Barot-Ciorbaru R
Int J Immunopharmacol; 1994; 16(5-6):469-73. PubMed ID: 7927995
[TBL] [Abstract][Full Text] [Related]
30. Anatomical and molecular imaging of skin cancer.
Hong H; Sun J; Cai W
Clin Cosmet Investig Dermatol; 2008 Oct; 1():1-17. PubMed ID: 21437135
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory effects of Bacillus firmus on mouse peritoneal cells in vitro.
Lomáková I; Petrásková P; Sterzl I; Prokesová L
Folia Microbiol (Praha); 2006; 51(3):243-7. PubMed ID: 17004658
[TBL] [Abstract][Full Text] [Related]
32. Antimetastatic effect of immunomodulators from Nocardia opaca in mice and rats activation of peritoneal macrophages by these fractions.
Barot-Ciorbaru R; Cornil I; Grand-Perret T; Poupon MF
Cancer Immunol Immunother; 1987; 25(2):111-8. PubMed ID: 3117366
[TBL] [Abstract][Full Text] [Related]
33. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma.
Battayani Z; Grob JJ; Xerri L; Noe C; Zarour H; Houvaeneghel G; Delpero JR; Birmbaum D; Hassoun J; Bonerandi JJ
Arch Dermatol; 1995 Apr; 131(4):443-7. PubMed ID: 7726587
[TBL] [Abstract][Full Text] [Related]
34. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
35. Detection of occult melanoma cells in sentinel lymph nodes and blood.
Reintgen DS; Conrad AJ
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S11-5. PubMed ID: 9122728
[TBL] [Abstract][Full Text] [Related]
36. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
37. An original method for submacroscopic metastases visualization in cases of cancer minimal residual disease.
Le Pape A; Barot-Ciorbaru R; Musset M; Baulieu JL; Jubault C; Lemarié E; Pourcelot L; Besnard JC; Nicolau C; Mathé G
Biomed Pharmacother; 1986; 40(10):392-8. PubMed ID: 3580508
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
